Item 1A. RISK FACTORS

There were no significant changes in the Company’s risk factors during the quarter ended March 31, 2023. For further information about the Company’s risk factors, refer to Part I, “Item 1A. Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities


Period	Total Number of Shares Purchased(1)	Average Price Paid per Share		Total Number of Shares Purchased as Part of a Publicly Announced Program(2)	Number of Shares Remaining that May be Purchased Under the Program(2)
January 1, 2023 to
January 31, 2023	71,704	$	84.012	71,445	87,740,560

February 1, 2023 to
February 28, 2023	3,400,945	82.029		2,085,050	85,655,510

March 1, 2023 to
March 31, 2023	2,208,616	78.371		2,208,616	83,446,894
Total	5,681,265	$	80.632	4,365,111	83,446,894

(1)Total shares purchased represents those shares purchased in the open market as part of the Company’s publicly announced share repurchase program described below, shares received as payment for the exercise price of stock option exercises, and shares received as payment for the withholding taxes on vested restricted stock awards. During the three-month period ended March 31, 2023, there were 1,316,154 shares received as payments for the minimum withholding taxes on vested restricted stock awards and for the exercise price of stock option exercises.

(2)On August 7, 2019, the Company’s Board of Directors approved the extension of the stock repurchase program through December 31, 2024 and the repurchase of up to an additional 100,000,000 shares under the extended program.

Previous: Item 4. CONTROLS AND PROCEDURES · Next: Item 6. EXHIBITS